Billionaires Holding VNDA

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 33.9M
    Shares Outstanding

  • 483.75M
    Market Cap

News & Insights

ABOUT

VNDA

Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt, a product for the treatment of schizophrenia; an...

Here’s Buffett’s Most Recent Acquisition

NEWS

Herbalife: Carl Icahn Comes Out On Top

READ MORE